KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Depreciation and Depletion: 2014-2024

Historic Depreciation and Depletion for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to $166.9 million.

  • BeOne Medicines' Depreciation and Depletion fell 48.98% to $35.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.2 million, marking a year-over-year increase of 5.40%. This contributed to the annual value of $166.9 million for FY2024, which is 107.54% up from last year.
  • Per BeOne Medicines' latest filing, its Depreciation and Depletion stood at $166.9 million for FY2024, which was up 107.54% from $80.4 million recorded in FY2023.
  • BeOne Medicines' 5-year Depreciation and Depletion high stood at $166.9 million for FY2024, and its period low was $30.9 million during FY2020.
  • Moreover, its 3-year median value for Depreciation and Depletion was $80.4 million (2023), whereas its average is $103.2 million.
  • Data for BeOne Medicines' Depreciation and Depletion shows a peak YoY surged of 107.54% (in 2024) over the last 5 years.
  • Over the past 5 years, BeOne Medicines' Depreciation and Depletion (Yearly) stood at $30.9 million in 2020, then skyrocketed by 44.59% to $44.7 million in 2021, then spiked by 39.25% to $62.3 million in 2022, then climbed by 29.11% to $80.4 million in 2023, then spiked by 107.54% to $166.9 million in 2024.